|
HS Code |
851249 |
| Chemical Name | 2-Bromo-4-nitroimidazole |
| Molecular Formula | C3H2BrN3O2 |
| Molecular Weight | 192.98 g/mol |
| Cas Number | 16112-55-9 |
| Appearance | Yellow to brown solid |
| Melting Point | 176-178°C |
| Solubility | Slightly soluble in water |
| Storage Temperature | Store at 2-8°C |
| Purity | Typically ≥98% |
| Synonyms | 4-Nitro-2-bromoimidazole |
| Inchi | InChI=1S/C3H2BrN3O2/c4-2-1-5-3(6-2)7(8)9/h1H,(H,5,6) |
| Smiles | C1=C(N(C=N1Br)[N+](=O)[O-]) |
As an accredited 2-Bromo-4-Nitroimidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 2-Bromo-4-Nitroimidazole, 10g: Supplied in an amber glass bottle with a screw cap, clearly labeled with hazard and handling information. |
| Shipping | 2-Bromo-4-Nitroimidazole is shipped in tightly sealed containers, protected from light and moisture. Packaging complies with international regulations for hazardous chemicals. The product is labeled clearly with hazard information and handled by trained personnel. Shipping is typically via ground or air freight, adhering to all safety and environmental guidelines. |
| Storage | 2-Bromo-4-Nitroimidazole should be stored in a cool, dry, and well-ventilated area, away from sources of moisture and incompatible substances such as strong oxidizers and bases. Keep the container tightly closed and clearly labeled. Store at room temperature and protect from light and heat. Use appropriate safety measures to prevent inhalation or skin contact during handling. |
Applications of 2-Bromo-4-Nitroimidazole in Industrial ManufacturingOur in-house production of 2-Bromo-4-Nitroimidazole supports critical downstream manufacturing steps for regulated pharmaceutical and specialty chemical markets. We ensure traceability, stability, and full batch consistency for industrial partners requiring precise application standards. 1. Pharmaceutical Intermediate for Oncology API SynthesisLarge-scale manufacturers of anticancer drugs utilize 2-Bromo-4-Nitroimidazole as a core intermediate during the construction of imidazole-based moiety structures, facilitating the introduction of nitro and bromo functionalities in targeted APIs. Production processes use this intermediate at specific bromination and nitration steps to achieve high-purity synthesis, supporting small molecule oncology compounds where substitution on the heterocycle is critical for activity. Product integrity is maintained through rigorous in-process controls and impurity profiling according to global regulatory frameworks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Veterinary Drug Intermediate (Antiprotozoal Compounds)Animal pharmaceutical producers employ 2-Bromo-4-Nitroimidazole as a building block in synthesis protocols for imidazole-derived antiprotozoal agents addressing livestock diseases. The material introduces specific electron-withdrawing groups required for pharmacological activity and bioavailability. Its batch reproducibility supports downline GMP-compliant processing and meets market-specific residue and impurity restrictions imposed on veterinary end products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Industrial Synthesis of Photographic ChemicalsProducers of specialty imaging chemicals use 2-Bromo-4-Nitroimidazole to formulate high-purity sensitizing agents and coating stabilizers for advanced silver halide photographic films. The compound serves both as a functionalized intermediate for crystal growth control and as an additive in emulsion blends, where the precise electronic configuration is necessary for contrast optimization and long-term stability of coated films. Production lines require exact material specification to avoid batch contamination and ensure consistent imaging quality under international QC protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chemical Reagent for Heterocyclic Compound LibrariesCustom synthesis labs and fine chemical producers utilize 2-Bromo-4-Nitroimidazole to generate diversified heterocycle libraries through Suzuki, Sonogashira, and nucleophilic aromatic substitution reactions. The electron-withdrawing substituents enable rapid scaffold elaboration in medicinal chemistry and agrochemical discovery programs, with purity and moisture content controlled by in-house analytical validation. Supply batches require clear labelling, reference spectrum, and comprehensive CoA to meet audit trails for regulated R&D pipelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-Bromo-4-Nitroimidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In our day-to-day work, time is precious and materials must perform. 2-Bromo-4-nitroimidazole has earned a reputation as a reliable, focused compound across many fields. At our facility, we take every batch seriously, blending skill with careful control to create a chemical that meets physicochemical targets. The work doesn't end with simply hitting those numbers—understanding what actually matters downstream drives our team’s decisions every day, from the cleanroom all the way to the filling line.
Each shipment heads out with a purity above 98%. We keep water content very low because a little extra moisture leads to headaches during synthesis. From years at the bench, our chemists know that even a trace of residual solvent or trace halide pushes reactions off course or wastes downstream yield. Careful control at every step makes life easier for researchers and production engineers using our material.
The structure of 2-bromo-4-nitroimidazole sets it apart—both functionally and in user experience. The bromo group offers a versatile anchor for nucleophilic substitution and cross-coupling. Imidazole rings keep showing up in both medicinal and material chemistry because their reactivity profile opens options for building bigger, more complex molecules. The nitro group directly influences electron-withdrawing behavior and creates the conditions for selective downstream conversion pathways. With this combination, scientists access scaffolds for drug design, ligands, and advanced materials.
Customers most often pull our 2-bromo-4-nitroimidazole off the shelf to create high-value intermediates. Medicinal chemists reach for it in heterocyclic library synthesis; agrochemical researchers employ it while preparing bioactive compounds. Custom peptide and nucleic acid projects can count on the high reactivity of the compound’s leaving groups. Over years of conversation with specialists, we have learned that small details—particle size, lot consistency, and absence of trace metals—matter more as regulations tighten and as screens become automated.
Several compounds compete for attention in imidazole chemistry. Some suppliers push 4-nitroimidazole or 2-chloro-4-nitroimidazole when customers ask about 2-bromo-4-nitroimidazole. The problem comes down to chemistry—swapping bromine for chlorine or hydrogen changes leaving group ability and alters reactivity. Chlorine holds on tighter and leads to slower reactions or incomplete conversions. We have carefully tracked comparative yields and impurity profiles for these analogues, and the brominated variant provides cleaner transformations, saving cost and time in purification.
Our direct synthesis from select nitration and bromination routes means that the end product contains fewer ring-opened or over-alkylated byproducts. Many customers report that once they move away from lower-cost, drawdown-grade materials, column fouling and downstream hydrolysis complaints drop sharply. It isn’t just theoretical; our own QC data and users’ reports back it up.
We don’t simply match certificate numbers to datasets. Specifications come from feedback and real benchwork. Typical purity of over 98% eliminates side products that build up over long campaigns. Moisture levels generally stay below 0.2%, based on Karl Fischer titration, since water picks up in storage and catalyzes unwanted side reactions. Bulk density stays consistent, supporting gravimetric dosing in semi-automated facilities. We monitor heavy metal content, keeping lead, mercury, and arsenic far beneath detection limits, which matters now more than ever.
Packaging makes a difference for delicate chemistry. Our sacks and drums seal tightly, guard against humidity swings, and prevent cross-contamination—especially important for multi-shift, high-throughput labs. We work closely with customers to tailor shipment sizes, sometimes experimenting with innovative packaging based on direct feedback from process engineers on the ground.
A few years ago, one customer faced unexplained batch-to-batch variation in their high-throughput screening results. Only after granular review of chromatography and GC traces did we trace the problem back to trace byproduct formation during bromination. As a response, we adjusted temperature profiles and in-process washes, cutting side product levels to almost undetectable. Experience teaches that open lines of communication solve problems, and we always welcome data from downstream partners.
Regulatory burdens keep rising for good reason. Even tiny levels of nitrosation byproducts trigger red flags in pharmaceuticals, and heavy metal transfer from raw materials means headaches for anyone facing revised European or North American standards. By controlling every controllable parameter, we help our partners avoid regulatory snags and requalification delays that slow time to market. Our records of internal audit trails, retained samples, and cross-checks stand open to qualified partners.
Everyone felt the pressure during supply chain disruptions. Our teams learned to plan ahead, secure reliable upstream sources of bromine, and keep inventories robust. There’s a big difference between lab-scale and commercial supply—for decades, we have kept the wheels turning even as markets tighten or shipping delays mount. We support contracts for monthly, quarterly, or annual supply, so customers don’t face project shutdowns or unforeseen shortages. Local warehousing and adaptive logistics teams help with fast, controlled deliveries.
Waste minimization and sustainable operations matter. We monitor effluents during synthesis, using solvent recovery where feasible and controlling nitrate and bromide releases. Staff training includes best practices for handling and offloading, since any slip increases both risk and cost. After years of audits, we have responded to both regulatory feedback and voluntary customer sustainability initiatives—by refining cooling steps and switching to closed dispensing, for example, worker exposure dropped to negligible levels, and we achieved both process safety and environmental compliance. Our own team’s sense of ownership comes from knowing hard work reduces the company footprint while supporting modern industry.
Good science depends on more than data sheets. Over the years, we’ve learned the most from feedback—in the form of purity test profiles, reports of batch failures, and even casual phone calls sharing unexpected reactivity trends. Sometimes users request tighter particle size cuts after seeing clumping or loose dust during dosing. Sometimes a synthetic step suddenly falters, and customers share HPLC or NMR traces with us to hunt down root causes together. Days working through tough issues side-by-side with experienced chemists have taught us humility, patience, and the importance of tracking every possible source of variation, even ones nobody expected.
We publish certificates for each lot, attach full traceability both forward and backward, and welcome questions about methodology and test procedures. We will not obscure or overstate quality; if an issue emerges, transparency comes first. Long-term partners trust us to flag even minor changes—such as a tweak in recrystallization solvent, or a shift in the lot size of upstream feedstock. Any gains from a short-term cover-up erode confidence far faster than a hard conversation about risk. Many of our partners have stayed with us across multiple project cycles because we stay honest even during short-term pain.
As a manufacturer seeing thousands of kilos pass through our lines, we see clear differences between our process and those of other suppliers and so-called resellers. Some repack aged stock or disguise mixed-origin product. We maintain uninterrupted temperature control and never break original packaging outside of process-mandated transfer. Documentation tracks every stage. While we know the urge to “grab a deal” tempts in tight markets, recovering from bad batches or inconsistent feedstock costs more in validation time, cleaning, and chronic downtime than the savings justify. Users see the difference immediately in consistent conversion rates, cleaner crystallizations, and repeatable test results.
Colleagues testing alternative sources often report something “a little off”—a subtle color change, new odor, or altered melting point range. Steady quality comes from process discipline: automated feed addition, tight impurity checks throughout, and final packaging in dehumidified spaces. We don’t just batch-check; we monitor trends and look for creeping changes that predict future problems. Years of seeing projects derailed over minor spec failures have built respect for these details.
Advantages become most evident in end uses where confidence matters. In pharmaceutical discovery, where every side product can mask biological activity or give a misleading signal, researchers report greater success when using high-purity 2-bromo-4-nitroimidazole. Material scientists have found that trace impurities lower the mechanical strength or fail to deliver intended electronic or optical effects in finished products. Repeat runs for polymer initiators or ligand precursors corroborate the need for the minimal batch-to-batch variability we insist on.
For complex synthesis projects, many rely on the specificity of the bromo and nitro groups—it gives better leaving ability and selectivity compared to alternative halogenated imidazoles. In practical terms, that means higher yields, fewer repeated purifications, and smoother translation from lab to pilot plant. Where price pressure pushes labs to experiment with generic replacements, the jump in labor, re-work, and test failures quickly erases any initial savings.
A tight product specification makes sense only in a partnership built on result sharing and clear expectations. We visit customer sites, observe how our material is handled, and collect both complaints and compliments. Many requests end up driving changes on our side—whether by refining filtration, updating drying regimes, or customizing shipment frequency. Rather than issuing rigid, one-time data packets, our team sees ongoing dialogue as the only real approach for critical starting materials.
Anyone can recite a list of technical specs, but few suppliers can support high-value chemistry with true continuity and support. Years of steady supply have taught us that quality comes from both technical control and a willingness to adapt as downstream needs evolve. Our understanding of 2-bromo-4-nitroimidazole and its best uses arises from tightly managed internal practice, coupled with real feedback from scientists at the frontiers of their fields.
With more stringent regulation, faster R&D cycles, and tighter budgets, companies have less room for error than ever before. We meet these challenges every day and stay committed to reliable, honest supply and technical support for this critical imidazole derivative. For those building the next generation of pharmaceuticals, agrochemicals, battery materials, or specialty reagents, every detail matters—and our team lives that reality on the production floor and in the laboratory.
We encourage open communication—whether for a new trial, ongoing supply, or troubleshooting a stubborn issue in your synthesis. We respond to changing specifications, regulatory demands, and market realities as partners, not pass-through points. If your process calls for unwavering consistency, detailed support, and a real commitment to chemical integrity, let’s work together to move science and manufacturing forward. Our doors, lines, and inboxes remain open to share both challenges and solutions.